SpaceX Stock Dips Below IPO Price Amidst Starship Test Flight Preparations
Money

SpaceX Stock Dips Below IPO Price Amidst Starship Test Flight Preparations

authorBy Mr. Money Mustache
DateJul 15, 2026
Read Time3 min

SpaceX's stock has recently experienced a notable decline, falling below its initial public offering price. This downturn has occurred despite a generally positive sentiment from Wall Street analysts, who remain optimistic about the company's long-term prospects. Meanwhile, SpaceX is actively preparing for a significant milestone: the upcoming test flight of its Starship rocket, an event eagerly anticipated by the aerospace industry.

SpaceX Stock Faces Market Headwinds as Starship Prepares for 13th Test Flight

In mid-July 2026, on a Wednesday, SpaceX (SPCX) shares encountered a significant setback, plummeting to an unprecedented low of $132.75. This figure represents a dip below its initial public offering (IPO) price of $135. The stock, which commenced trading at $150 on June 12 and reached its all-time high of $225.64 just four days later on June 16, has since been under considerable pressure. The current valuation reflects a more than 30% decrease from its peak and an approximate 12% decline since the beginning of the year, posing a challenge for investors who had observed a substantial surge in SpaceX's private-market value in the months leading up to its IPO.

Despite this market performance, the majority of Wall Street analysts maintain a bullish stance on SpaceX. According to insights from Yahoo Finance, 27 out of 31 analysts recommend a 'Buy' or 'Strong Buy' rating for the stock, with an average price target of $242. Needham, a prominent financial firm, recently reaffirmed its 'Buy' rating and elevated its price target from $200 to $250, underscoring a clear disparity between market sentiment and analyst valuations.

Adding to the company's unfolding narrative, a pivotal event is scheduled to occur on Thursday night: the 13th test flight of SpaceX's Starship rocket. This colossal vehicle, the most powerful ever constructed, represents the second launch of Starship's Version 3, an enhanced design introduced less than two months prior. The previous test flight in May saw the Super Heavy booster suffer heat damage during separation and ultimately fail its return sequence due to engine malfunction. This upcoming launch is crucial for SpaceX's ambitious endeavors, which include heavy-lift operations, satellite deployment, and future manned missions to the moon and Mars. However, even ardent supporters, such as Evercore ISI's Kutgun Maral, acknowledge that Starship's scalability remains an unproven aspect, especially as its inaugural operational payload launch is slated for the latter half of this year.

The recent dip in SpaceX's stock price, despite the company's pioneering aerospace ventures and Wall Street's optimistic long-term projections, presents an interesting paradox. It highlights the inherent volatility and speculative nature often associated with innovative, high-growth companies operating in frontier technologies. The upcoming Starship test flight will not only be a technical litmus test for SpaceX but also a significant indicator for how the market perceives the tangible progress and future potential of its groundbreaking projects. This situation underscores the delicate balance between groundbreaking innovation, market expectations, and the practical challenges of scaling complex aerospace technologies. It will be compelling to observe how these elements converge and influence SpaceX's trajectory in the coming months.

More Articles
Money
Millionaire Habits: The Disciplined Approaches Driving Wealth Creation
A recent UBS Global Wealth Report reveals that approximately 440,000 new millionaires emerged in the U.S. last year, largely due to robust financial markets. This surge isn't attributed to quick wins but rather to consistent, disciplined financial practices such as long-term investing and strategic saving. Influential figures like Warren Buffett and Dave Ramsey advocate for patience and continuous learning, emphasizing that wealth accumulation is a gradual process rather than an overnight phenomenon.
By Chika UwazieJul 15, 2026
Money
Lexeo Therapeutics: A Promising Gene Therapy Stock Under $10
Lexeo Therapeutics, a clinical-stage genetic medicine company, is gaining attention as a potential high-growth stock. The company recently finalized a crucial trial protocol for its gene-based therapy candidate, LX2006, aimed at treating Friedreich's ataxia cardiomyopathy. Despite a recent price target reduction by JPMorgan, the stock maintains an 'Overweight' rating with significant upside potential, positioning it as a compelling investment in the biotechnology sector.
By Ramit SethiJul 15, 2026
Money
Microsoft CEO Joins Palantir's AI Warning
Microsoft CEO Satya Nadella has echoed concerns previously raised by Palantir CEO Alex Karp regarding the hidden costs of AI. Both leaders warn that businesses using AI models are not only paying monetarily but also surrendering valuable proprietary data and institutional knowledge, effectively paying twice for intelligence. This creates a strategic vulnerability, potentially strengthening Palantir's specialized AI solutions that protect corporate data.
By Bola SokunbiJul 15, 2026
Money
Laughing Water Capital Anticipates Strong Returns from NextNav (NN) Investment
Laughing Water Capital achieved remarkable Q2 2026 portfolio returns, driven by strategic acquisitions and undervalued stock investments. The firm highlights NextNav Inc. (NN) as a key holding, despite regulatory uncertainties surrounding its 5G spectrum plans. NextNav, a PNT solutions provider, is actively working to resolve FCC approvals, showcasing its technology's non-interference capabilities through real-world testing. The investment firm remains confident in NextNav's long-term potential as it cleans up its balance sheet and navigates regulatory hurdles.
By T. Harv EkerJul 15, 2026
Money
Boyd Gaming: A Strategic Investment Ahead of Earnings with Significant Upside Potential
Boyd Gaming (NYSE:BYD) presents an attractive investment opportunity with a projected 17% upside, driven by strong quarterly EBITDAR, an aggressive share buyback program, and a favorable valuation. The company's robust balance sheet and consistent earnings beats position it strongly against competitors, making it a compelling buy before its July 23 earnings release.
By Natalie PaceJul 15, 2026